Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Bristol Myers Squibb becomes UK's first pharma company to be accredited as 'menopause friendly'

Pharmaceutical giant Bristol Myers Squibb has become the first pharmaceutical company in the UK to be accredited as a 'menopause friendly workplace'.

The accreditation, awarded by an independent panel of judges, recognises employers who put diversity, inclusion and wellbeing at the centre stage of their business.


Bristol Myers Squibb (BMS) said it rung in the changes in recognition of the fact that nearly eight of 10 menopausal women are in work and that this is the fastest growing demographic in the workforce.

Panel members described BMS UK&I’s application as “outstanding” and acknowledged "the huge strides they have made to help normalise the menopause" by fostering an inclusive culture.

Support and education

The company said it has pioneered a range of menopause-friendly initiatives to support women at work since last March which include:

• A detailed internal menopause guidance document to support and educate all UK&I staff

o This includes details on the different types of menopause, how symptoms can affect daily work, and signposting to internal and external resources

• A reasonable adjustments form to help accommodate staff experiencing menopausal symptoms

• A Rapid Access Female Treatment Service (RAFT) that allows employees experiencing severe menopausal symptoms in the workplace to be referred to a consultant gynaecologist who is an accredited British Menopause Society specialist

• Training 17 menopause advocates across UK&I sites who help educate, raise awareness, and signpost colleagues on their menopause journey

• A menopause portal developed for employees, by employees, to access support and information

• Training more than 60 per cent of the UK&I workforce on menopause awareness

Scott Cooke, general manager for BMS UK&I, said: “I am so proud that Bristol Myers Squibb UK&I is the first pharmaceutical company to have been officially awarded Menopause Friendly status, highlighting our continued commitment to ensuring that all people affected by the menopause feel supported at work.

"I am delighted that we are helping lead the way in changing how businesses think about the menopause, and we remain passionate about accelerating change in workplace best practice and fostering an inclusive culture where everyone can bring their authentic selves to work every day.”

Members of the accreditation board include Professor Jo Brewis, lead author of the Government Equalities Office report on ‘The effects of menopause transition on women’s economic participation in the UK’, and Bernice Allport MBE, former chair of the cross-government Menopause Network.

More For You

Free morning-after pill at pharmacies to end postcode lottery for patients

Pharmacy technicians will be allowed to supply of drospirenone for contraception under PGD,

gettyimages

Pharmacy contract: Free morning-after pill to be available at pharmacies soon

The UK government has announced that, for the first time ever, the ‘morning-after pill’ or emergency contraceptive pill will be available free of charge at pharmacies on the NHS, ending the postcode lottery women face in accessing the medicine and reducing inequalities.

The Department of Health and Social Care (DHSC) has confirmed a record £3.073 billion funding package for community pharmacies in 2025/26, alongside an additional £215 million to sustain Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Royal College status: The PDA calls for ‘meaningful and collaborative dialogue’

The profession’s success will depend on collaboration across all sectors, says PDA.

gettyimages

Royal College vote: Less than 7% of GB pharmacists in favour, says PDA

The Pharmacists’ Defence Association (PDA) has criticised the Royal Pharmaceutical Society (RPS) for moving too quickly to a ballot on its proposed transition to a Royal College, arguing that it resulted in low participation from pharmacists in Great Britain.

Announcing the results of the special resolution vote, the RPS said that the outcome was a “clear mandate” in favour of the transformative change.

Keep ReadingShow less
RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less